Keep Informed on Legal and Compliance Developments Affecting Diagnostic Labs
Best practices and expert insight to help lab professionals comply with regulations and identify strategic trends in business and technology
Already a Subscriber? Log in Here
Lab Industry Advisor Subscription
Keeps you up to date on the latest legal, compliance, and business developments affecting the lab industry, while offering analysis and insight to ensure your lab’s success.
![Essential](https://www.g2intelligence.com/wp-content/uploads/2023/11/Essential.png)
![62934_G2_Subscription Website Images_JL V1](https://www.g2intelligence.com/wp-content/uploads/2023/11/62934_G2_Subscription-Website-Images_JL-V1.png)
![Special-Report](https://www.g2intelligence.com/wp-content/uploads/2023/11/Special-Report.png)
![62934_G2_Subscription Website Images_JL V12](https://www.g2intelligence.com/wp-content/uploads/2023/11/62934_G2_Subscription-Website-Images_JL-V12.png)
![Special-Analysis](https://www.g2intelligence.com/wp-content/uploads/2023/11/Special-Analysis.png)
![Elite](https://www.g2intelligence.com/wp-content/uploads/2023/11/Elite.png)
Additional Business Intelligence Offerings
Lab Industry Advisor Subscriptions Include
![paper_magnifing_glass_512](https://www.g2intelligence.com/wp-content/uploads/2023/11/paper_magnifing_glass_512.png)
Analysis and insight on key compliance, legal, and business developments affecting laboratories
- Updates on changes to regulations
- Healthcare-related laws
- FDA approvals
- Business deals in the diagnostics space, and more
Latest Articles
New FDA LDTs Guidance Offers Useful Summary, But Questions Remain
Recently released document for small labs offers a more digestible version of the final rule requirements but still lacks key details
Genetic Testing Guidelines for Hereditary Cancer Miss Many At Risk
From - Diagnostic Testing & Emerging Technologies
The National Comprehensive Cancer Network genetic testing criteria for hereditary cancer miss almost one in five at-risk for…
Compliance Perspectives: Feds Using Medicare Laws to Prosecute Non-Medicare Arrangements
From - Lab Compliance Advisor
Myth: Risk of federal prosecution for health fraud and abuse applies only when you deal with…
State Law Round-up: New Privacy Breach Notification Laws Potentially Affecting Labs
From - Lab Compliance Advisor
As illustrated by the recent MIE settlement (click here for the story), security breaches involving patients' electronic protected health information…
Dealing with Consumers: Using Patient Online Reviews to Boost Your Lab Business
From - Laboratory Industry Report
Patients are making increasing use of physician rating and review sites to comment on their medical experiences the way diners do with restaurants. And as with…
Google This: Labs Partner with Tech Giant
From - National Intelligence Report
In recent months, several diagnostic companies have announced alliances with Google, and all involve…
Enforcement Trends: Investment Return on Fraud Fighting Continues to Decline
From - National Intelligence Report
Although it's still a profitable endeavor, enforcing federal health care fraud laws isn't providing the investment returns of yesteryears…
Routine Urine Test Can Screen for Medication Adherence at Primary Care Visit
From - Diagnostic Testing & Emerging Technologies
A single urine spot sample can be used to objectively screen for nonadherence to diabetes medications in the…